{"database": "lobbying", "table": "lobbying_activities", "rows": [[841962, "8b791f08-0912-43ab-8342-78f1475ca1bf", "Q3", "WINSTON & STRAWN LLP", 41682, "FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC )", 2009, "third_quarter", "PHA", "Represent the client on issues related to assuring a safe, reliable supply of heparin and vancomycin.", "Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2009-10-19T19:17:02-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["841962"], "units": {}, "query_ms": 1.672849990427494, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}